Τετάρτη 1 Νοεμβρίου 2017

Melanoma Drugs Effective as Adjuvants [News in Brief]

BRAF-targeted strategies and PD-1–blocking immunotherapy are more effective adjuvant therapies than currently approved options for patients with high-risk resectable melanoma. However, choosing the best agent for patients with BRAF-mutated disease remains a challenge.



http://ift.tt/2iSMt0l

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου